8-K - Seres Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

. Results of Operations and Financial Condition. On November 5, 2025, Seres Therapeutics, Inc. (the “Company”) announced its financial results for the quarter e

Financial Results

7.01

. Regulation FD Disclosure. On November 5, 2025, the Company posted an updated corporate presentation in the “Investors and News” portion of its website at www.

Regulation Fd

9.01

. Financial Statements and Exhibits. (d) Exhibits The following Exhibits 99.1 and 99.2 relate to Items 2.02 and 7.01, respectively, and shall be deemed to be fu

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2